期刊文献+

PIK3CA基因突变数字PCR参考测量方法研究 被引量:1

Research on Digital PCR Reference Measurement Method of PIK3CA Gene Mutation
下载PDF
导出
摘要 PIK3CA突变检测是实现肿瘤个体化治疗的重要预测因子。以PIK3CA为目的基因,选择E542K、E545K、H1047R三个热点突变,建立对其准确定量检测的微滴式数字聚合酶链式反应(ddPCR)方法。优化退火温度、引物探针浓度等条件,对方法特异性、线性范围、重复性等方面进行考察。结果表明,建立的ddPCR检测方法精密度好,在突变丰度(0.05~82.75)%范围内相对标准偏差值介于(0.392~14.031)%,准确性高,与重量法的相关系数达到99.91%、99.98%、99.94%;在突变丰度0.2%以上,方法的重复性可达5%以内;在突变丰度0.2%以下,重复性保持在15%以下。在20μL反应体系中3个热点突变的空白限分别为0.03%、 0.04%、0.04%,检测下限和定量下限均为0.05%。因此,所建立的PIK3CA基因E542K、E545K及H1047R位点突变的ddPCR参考测量灵敏度高,重复性好,在癌症诊断、个体化用药指导和预后方面具有良好的应用。 The mutation of phosphatidylinositol 3-kinase catalytic subunitɑ(PIK3CA)gene is closely related to the occurrence and development of a variety of tumors.It has a high mutation rate in human tumors and is expected to be a new target for accurate early diagnosis and treatment of tumors.Point,provide a theoretical basis for individualized treatment.At present,PIK3CA mutation detection has become an important predictor of individualized tumor therapy.PIK3CA mutation detection is an important predictor for realizing individualized treatment of tumors.Therefore,using PIK3CA as the target gene,three hotspot mutations,E542K,E545K,and H1047R,were selected to establish a droplet digital polymerase chain reaction(ddPCR)method for accurate and quantitative detection.Optimize the annealing temperature,primer probe concentration and other conditions,and investigate the method specificity,linear range,repeatability and other aspects.The annealing temperature,primer probe concentration and other conditions were optimized,and the specificity,linear range and repeatability of the method were investigated.The results show that the established ddPCR detection method has good precision,the relative standard deviation value is between 0.392%~14.031%in the abundance range of 0.05%~82.75%,and the accuracy is high.The correlation coefficient with gravimetric method reach 99.91%,99.98%,99.94%,when the mutation abundance is above 0.2%,the repeatability of the method can reach within 5%,and when the mutation abundance is below 0.2%,the repeatability remains below 15%.The limit of blank of the three hot spot mutations in the 20μL reaction system are 0.03%,0.04%,0.04%,and the lower limit of detection and lower limit of quantification are both 0.05%.Therefore,the ddPCR reference measurement of PIK3CA gene E542K,E545K and H1047R mutations has high sensitivity and good repeatability, and has good applications in cancer diagnosis,individualized medication guidance and prognosis.
作者 王蕾蕾 王霞 邢德纯 董莲华 杨靖亚 WANG Lei-lei;WANG Xia;XING De-chun;DONG Lianhua;YANG Jing-ya(College of Food Sciences&Technology,Shanghai Ocean University,Shanghai 201306,China;Frontier Metrology Science Center,National Institute of Metrology,Beijing 100029,China)
出处 《计量学报》 CSCD 北大核心 2023年第3期368-376,共9页 Acta Metrologica Sinica
基金 国家质量基础共性关键技术重点研发专项(2017YFF0204605) 中国计量科学研究院基本科研业务费(AKY1929)。
关键词 计量学 PIK3CA 基因突变 数字PCR 定量 metrology PIK3CA gene mutation digital PCR quantitative
  • 相关文献

参考文献13

二级参考文献83

  • 1郑桂丽,廖绍安,翟俊辉,纪伟尚,杨瑞馥.环境中“活的非可培养(VBNC)”细菌的研究进展[J].微生物学免疫学进展,2004,32(4):58-66. 被引量:23
  • 2潘良文,田风华,张舒亚.转基因抗草丁膦油菜籽中Barnase基因的实时荧光定量PCR检测[J].中国油料作物学报,2006,28(2):194-198. 被引量:15
  • 3Volinia S, Hiles I, Ormondroyd E, et al. Molecular clo- ning, eDNA sequence, and chromosomal localization of the human phosphatidylinositol 3-kinas p110 alpha ( PIK3 CA) gene [ J ]. Genomics, 1994, 24:472-477.
  • 4White VL, Rickman C, Bond CE, et al. Oncogenic PIK3CA mutations in colorectal cancers and polyps [ J ]. Int J Canc- er, 2012, 131:813-820.
  • 5Dupont JJ, Laenkholm AV, Knoop A, et al. PIK3CA muta- tions may be discordant between primary and metastatic disease in breast cancer [ J ]. Clin cancer Res, 2011, 17 : 667-677.
  • 6Lee JW, Soung YH, Kim SY, et al. PIK3CA gene is fre- quently mutated in breast and hepatocellular carcinomas [ J]. Oncogene, 2005, 24 : 1477-1480.
  • 7Philp AJ, Campbell IG, Leet C, et al. The phosphatidyli- nositol 3'-kinase p85alpha gene is an oncogene in human o- varian and colon tumors [ J ]. Cancer Res, 2001, 61:7426-7429.
  • 8SamuelsY, Wang Z, Bardelli A, et al. High frequency of mutations of the PIK3CA gene in human cancers [ J ]. Sci- ence, 2004, 304:554-554.
  • 9Corso G, Velho S, Peredes J, et al. Oncogenic mutations in gastric cancer with mietosatellite instability [ J ]. Eur J Cancer, 2011,47:443-451.
  • 10Bang YJ, Van Cutsem E, Feyereislova A, et al. Trastu- zumab in combination with chemotherapy versus chemother- apy alone for treatment of HER2-positive advanced gastric or gastro-oesophageal junction cancer (TOGA) : a phase 3, open-label, randomised controlled trial[ J]. Lancet, 2010, 376: 687-697.

共引文献108

同被引文献1

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部